Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07310797) titled 'Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Condition:
Ureteral Calculi
Intervention:
Drug: Mirabegron
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: January 1, 2026
Target Sample Size: 500
Countries of Recruitment:
Taiwan
To know more, visit https://clinicaltrials.gov/study/NCT07310797
Discla...